The use of innovative domestic interferon inducer for the prevention and treatment of acute respiratory viral infections in children

The article presents data on the place of the modern endogenous interferon inducers in the treatment and prevention of influenza and ARVI in children and the mechanisms of action. The focus is on the domestic antiviral innovation Kagocel which demonstrated high clinical efficacy and safety in a numb...

Full description

Bibliographic Details
Main Author: Y. L. Mizernitskiy
Format: Article
Language:Russian
Published: Remedium Group LLC 2016-12-01
Series:Медицинский совет
Subjects:
Online Access:https://www.med-sovet.pro/jour/article/view/8
_version_ 1797841787069399040
author Y. L. Mizernitskiy
author_facet Y. L. Mizernitskiy
author_sort Y. L. Mizernitskiy
collection DOAJ
description The article presents data on the place of the modern endogenous interferon inducers in the treatment and prevention of influenza and ARVI in children and the mechanisms of action. The focus is on the domestic antiviral innovation Kagocel which demonstrated high clinical efficacy and safety in a number of multi-center, blind, placebo-controlled studies of the treatment and prevention of ARVI/flu in children over 2 years old.
first_indexed 2024-04-09T16:37:02Z
format Article
id doaj.art-b61fae7757fb457aad43fbb7e9368f9d
institution Directory Open Access Journal
issn 2079-701X
2658-5790
language Russian
last_indexed 2024-04-09T16:37:02Z
publishDate 2016-12-01
publisher Remedium Group LLC
record_format Article
series Медицинский совет
spelling doaj.art-b61fae7757fb457aad43fbb7e9368f9d2023-04-23T06:56:51ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902016-12-0111505310.21518/2079-701X-2016-1-50-538The use of innovative domestic interferon inducer for the prevention and treatment of acute respiratory viral infections in childrenY. L. Mizernitskiy0Clinical Research Institute of Pediatrics named after acad. Y.E. VeltischevThe article presents data on the place of the modern endogenous interferon inducers in the treatment and prevention of influenza and ARVI in children and the mechanisms of action. The focus is on the domestic antiviral innovation Kagocel which demonstrated high clinical efficacy and safety in a number of multi-center, blind, placebo-controlled studies of the treatment and prevention of ARVI/flu in children over 2 years old.https://www.med-sovet.pro/jour/article/view/8детипрофилактика и лечение орви/гриппаиндукторы интерферонакагоцелchildrenprevention and treatment of arvi/fluinterferon inducerskagocel
spellingShingle Y. L. Mizernitskiy
The use of innovative domestic interferon inducer for the prevention and treatment of acute respiratory viral infections in children
Медицинский совет
дети
профилактика и лечение орви/гриппа
индукторы интерферона
кагоцел
children
prevention and treatment of arvi/flu
interferon inducers
kagocel
title The use of innovative domestic interferon inducer for the prevention and treatment of acute respiratory viral infections in children
title_full The use of innovative domestic interferon inducer for the prevention and treatment of acute respiratory viral infections in children
title_fullStr The use of innovative domestic interferon inducer for the prevention and treatment of acute respiratory viral infections in children
title_full_unstemmed The use of innovative domestic interferon inducer for the prevention and treatment of acute respiratory viral infections in children
title_short The use of innovative domestic interferon inducer for the prevention and treatment of acute respiratory viral infections in children
title_sort use of innovative domestic interferon inducer for the prevention and treatment of acute respiratory viral infections in children
topic дети
профилактика и лечение орви/гриппа
индукторы интерферона
кагоцел
children
prevention and treatment of arvi/flu
interferon inducers
kagocel
url https://www.med-sovet.pro/jour/article/view/8
work_keys_str_mv AT ylmizernitskiy theuseofinnovativedomesticinterferoninducerforthepreventionandtreatmentofacuterespiratoryviralinfectionsinchildren
AT ylmizernitskiy useofinnovativedomesticinterferoninducerforthepreventionandtreatmentofacuterespiratoryviralinfectionsinchildren